Three-in-Four National Cancer Plans Lack Funding Strategies
Global Cancer Plans Show Progress, But Access Gaps Persist
New Review Highlights Disparities in Cancer Care Access Worldwide
A major international review of national cancer control plans (NCCPs) reveals important progress in areas like financing and early detection, but also underscores persistent disparities in access to life-saving treatments, particularly in low-income countries.
The study, published in The lancet Oncology, analyzed 156 national cancer and non-communicable disease (NCD) plans from around the world. Coordinated by The Union for International Cancer Control (UICC) in collaboration with the International Cancer Control Partnership (ICCP) and others, the review offers a critical snapshot of the global landscape of cancer control efforts.
“The advancements in early detection and treatment strategies, and also a greater inclusion of financing strategies, are particularly commendable,” said Cary Adams, CEO of UICC. “Though, the fact that nearly 75% of plans still do not include strategies to fund the cancer control ambition is disappointing.”
Key Findings:
Increased Funding: The percentage of NCCPs including financing strategies jumped from 7% in 2018 to 27% in 2023, signaling a growing recognition of the need for dedicated resources to combat cancer effectively.
Specific and Integrated Plans: Many plans now feature clear targets, timelines, and adhere to the SMART criteria (Specific, Measurable, Achievable, Realistic, Time-bound), indicating a move towards more focused and actionable strategies.
Early Detection and Treatment Gaps: While 90% of plans include strategies for early detection of breast and cervical cancer, only 50% include radiotherapy strategies, and a mere 26% reference the WHO’s Model Lists of Essential Medicines. This highlights a critical disconnect between screening programs and timely access to treatment.
Limited Evidence-Based Recommendations: Only 23% of NCCPs and 12% of NCD plans referenced evidence-based recommendations, underscoring a need for stronger scientific grounding in policy decisions.
Addressing the Global Divide
The review also sheds light on the stark disparities in access to cancer care between high- and low-income countries.
“Only about 10% of cancer patients in low-income countries have access to radiotherapy, compared to 90% in high-income countries,” said lisa Stevens, co-author and director of the Division of Programme of Action for Cancer Control (PACT) at the International Atomic Energy Agency. “This review highlights both the progress made and the gaps that persist, particularly in access to this life-saving technology.”
Moving Forward: A Call for Collaboration and Innovation
The study’s authors emphasize the need for continued international collaboration, increased investment in cancer control, and leveraging technology and innovation to strengthen NCCPs.
“National cancer control plans are an possibility to integrate current scientific knowledge into global cancer control policies and practice,” said Satish Gopal, director of the Centre for Global Health at the US National Cancer Institute. ”Currently, only 23% of NCCPs include evidence-based recommendations, highlighting an important area where dissemination and implementation of cancer research can impact policy and ultimately cancer care.”
The findings will be presented at the Cancer Planners Forum in May in Geneva, bringing together 100 national stakeholders to share best practices and knowledge for NCCP planning, development, and implementation. This forum will provide a platform for stakeholders to discuss the results and explore ways to enhance cancer control strategies globally.
Global Cancer Plans Making Strides, But gaps in Access Remain: An Exclusive Interview with Dr.Emily Carter
NewsDirectory3.com – Recent global initiatives to combat cancer are showing promising progress, but significant disparities in access to diagnosis, treatment, and care persist, highlighting the urgent need for equitable healthcare solutions. Dr. emily Carter, a leading cancer researcher and public health specialist at the Institute for Global Health Solutions, sheds light on the advancements made and the challenges that lie ahead.
NewsDirectory3.com: Dr. Carter, there’s been a lot of talk about global cancer plans. Can you tell us about these initiatives and what thay aim to achieve?
Dr. Carter: Absolutely. Over the past few years, numerous countries and international organizations have launched comprehensive cancer control plans. These plans are multifaceted, targeting prevention, early detection, diagnosis, treatment, and palliative care. The World Health Organization’s Global Initiative for Cancer Control is a prime example, aiming to significantly reduce the global cancer burden by 2030.
NewsDirectory3.com: What progress have we seen so far?
Dr. Carter: We’ve witnessed some encouraging developments. There’s been a growing focus on vaccination programs targeting cancer-causing viruses like HPV, leading to a decline in certain cancers.Increased awareness of cancer symptoms and risk factors has led to earlier diagnoses in many regions. Additionally, advancements in treatment options like targeted therapies and immunotherapy are offering new hope to patients.
NewsDirectory3.com: Despite these positive developments, you mentioned access gaps.Can you elaborate on those?
Dr. Carter: Unluckily, access to quality cancer care remains a major challenge, especially in low- and middle-income countries. Many people in these regions lack access to basic diagnostic tools, essential medications, and specialized treatment facilities.This results in delayed diagnoses, inadequate treatment, and ultimately, poorer outcomes.
NewsDirectory3.com: What are some of the key factors contributing to these access disparities?
Dr. carter: A complex interplay of factors is at play.
Economic limitations restrict access to healthcare services and essential medications.
Limited availability of trained healthcare professionals, notably oncologists, in underserved regions hinders timely diagnosis and treatment.
weak healthcare infrastructure, including insufficient diagnostic equipment and treatment facilities, poses a major barrier. Social determinants of health, such as poverty, education, and geographic location, also play a significant role in exacerbating these inequalities.
NewsDirectory3.com: What can be done to address these challenges?
Dr. Carter: Addressing this global health inequity demands a multi-pronged approach.
strengthening healthcare systems in low- and middle-income countries through increased investment in infrastructure, healthcare workforce, and essential medical supplies is crucial.
Promoting universal healthcare coverage to ensure financial access to cancer care for all, regardless of their economic status, is vital.
Investing in research and growth of affordable, accessible cancer treatments and diagnostic tools tailored to the specific needs of these regions is paramount.
Empowering communities through health education and awareness programs can promote early detection and encourage preventive measures. International collaboration and knowledge sharing are essential to accelerate progress
NewsDirectory3.com: Dr. Carter,thank you for this insightful discussion. Your expertise sheds light on the urgent need for coordinated efforts to ensure equitable access to cancer care globally.
Disclaimer:
The views expressed by Dr. Emily Carter in this interview are her own and do not necessarily reflect the official stance of NewsDirectory3.com.